Matthew P. Blischak's most recent trade in Finch Therapeutics Group Inc was a trade of 962,899 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group Inc | Matthew P. Blischak | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 962,899 | 962,899 | - | - | Stock Option (right to buy) |